US3565924A
(en)
*
|
1968-07-01 |
1971-02-23 |
Wisconsin Alumni Res Found |
25-hydroxycholfcalciferol
|
US3833622A
(en)
|
1969-03-17 |
1974-09-03 |
Upjohn Co |
Crystalline 25-hydroxycholecalciferol hydrate and structurally related compounds
|
US3974272A
(en)
|
1972-09-01 |
1976-08-10 |
Merck & Co., Inc. |
Palatable cholestyramine coacervate compositions
|
US3880894A
(en)
*
|
1974-05-24 |
1975-04-29 |
Wisconsin Alumni Res Found |
1,25-Dihydroxyergocalciferol
|
US4004003A
(en)
*
|
1974-08-28 |
1977-01-18 |
The Upjohn Company |
25-Hydroxycalciferol compounds for treatment of steroid-induced osteoporosis
|
US4230701A
(en)
*
|
1979-03-21 |
1980-10-28 |
Hoffmann-La Roche Inc. |
Administration of biologically active vitamin D3 and vitamin D2 materials
|
US4335120A
(en)
*
|
1979-03-21 |
1982-06-15 |
Hoffmann-La Roche Inc. |
Administration of biologically active vitamin D3 and vitamin D2 materials
|
JPS55139320A
(en)
|
1979-04-16 |
1980-10-31 |
Teijin Ltd |
Bone metabolism regulator
|
US4442093A
(en)
|
1981-05-15 |
1984-04-10 |
Kureha Kagaku Kogyo Kabushiki Kaisha |
Method for administering 24,25-dihydroxycholecalciferol to persons suffering from hypercalcemia
|
JPS57188520A
(en)
|
1981-05-15 |
1982-11-19 |
Kureha Chem Ind Co Ltd |
Antihyperkalemia
|
JPS5832823A
(ja)
*
|
1981-08-20 |
1983-02-25 |
Chugai Pharmaceut Co Ltd |
脱癌剤
|
JPS58206524A
(ja)
*
|
1982-05-26 |
1983-12-01 |
Kureha Chem Ind Co Ltd |
抗腫瘍剤
|
US4448721A
(en)
|
1982-09-20 |
1984-05-15 |
Wisconsin Alumni Research Foundation |
Hydroxyvitamin D2 compounds and process for preparing same
|
US4721613A
(en)
*
|
1982-12-13 |
1988-01-26 |
Alza Corporation |
Delivery system comprising means for shielding a multiplicity of reservoirs in selected environment of use
|
JPS59155309A
(ja)
*
|
1983-02-22 |
1984-09-04 |
Teijin Ltd |
活性型ビタミンd↓3類組成物
|
US4684524A
(en)
*
|
1984-03-19 |
1987-08-04 |
Alza Corporation |
Rate controlled dispenser for administering beneficial agent
|
US4555364A
(en)
*
|
1984-11-01 |
1985-11-26 |
Wisconsin Alumni Research Foundation |
Method for preparing 1-hydroxyvitamin D compounds
|
US4695591A
(en)
*
|
1985-03-29 |
1987-09-22 |
Schering Corporation |
Controlled release dosage forms comprising hydroxypropylmethylcellulose
|
US4668517A
(en)
*
|
1985-04-04 |
1987-05-26 |
Norwich Eaton Pharmaceuticals, Inc. |
Furazolidone dosage form
|
DE3676235D1
(de)
*
|
1985-06-04 |
1991-01-31 |
Teijin Ltd |
Arzneizubereitung mit verzoegerter wirkstoffabgabe.
|
JPS61293911A
(ja)
|
1985-06-24 |
1986-12-24 |
Teisan Seiyaku Kk |
徐放化製剤
|
ATE59552T1
(de)
|
1986-04-05 |
1991-01-15 |
Scherer Gmbh R P |
Gelatinekapseln mit gesteuerter wirkstofffreisetzung und verfahren zur herstellung derselben.
|
US5167965A
(en)
|
1987-02-09 |
1992-12-01 |
The Dow Chemical Company |
Palatable cholestyramine granules, tablets and methods for preparation thereof
|
US4892821A
(en)
|
1987-07-08 |
1990-01-09 |
Taisho Pharmaceutical Co., Ltd. |
Method for preparing vitamin D compounds
|
US4997824A
(en)
|
1987-07-22 |
1991-03-05 |
Teva Pharmaceutical Industries Ltd. |
Combination of cholecalciferol derivatives for the treatment of renal bone disease
|
US5869473A
(en)
*
|
1988-08-02 |
1999-02-09 |
Bone Care International, Inc. |
Method for treating and preventing hyperparathyroidism
|
US5104864A
(en)
*
|
1988-08-02 |
1992-04-14 |
Bone Care International, Inc. |
Method for treating and preventing loss of bone mass
|
US5602116A
(en)
*
|
1988-08-02 |
1997-02-11 |
Bone Care International, Inc. |
Method for treating and preventing secondary hyperparathyroidism
|
JP2893191B2
(ja)
*
|
1988-11-08 |
1999-05-17 |
武田薬品工業株式会社 |
放出制御性マトリックス剤
|
JP2525478B2
(ja)
|
1989-03-01 |
1996-08-21 |
帝人株式会社 |
安定性の改良された活性型ビタミンd▲下3▼類固型製剤
|
JPH02240024A
(ja)
|
1989-03-13 |
1990-09-25 |
Ss Pharmaceut Co Ltd |
活性型ビタミンd↓3類製剤用組成物
|
US5026559A
(en)
*
|
1989-04-03 |
1991-06-25 |
Kinaform Technology, Inc. |
Sustained-release pharmaceutical preparation
|
GB9004544D0
(en)
|
1990-03-01 |
1990-04-25 |
Leo Pharm Prod Ltd |
Novel treatment ii
|
JP2845342B2
(ja)
|
1990-04-28 |
1999-01-13 |
大正製薬株式会社 |
ビタミンd▲下3▼誘導体含有固形製剤組成物
|
JPH04198129A
(ja)
|
1990-11-28 |
1992-07-17 |
Sumitomo Pharmaceut Co Ltd |
活性型ビタミンd↓3類含有組成物
|
JP2893140B2
(ja)
|
1990-11-30 |
1999-05-17 |
エスエス製薬株式会社 |
安定なビタミンd製剤
|
JPH04288016A
(ja)
|
1991-03-14 |
1992-10-13 |
Tokai Capsule Kk |
活性型ビタミンd3類軟カプセル剤の製造方法
|
CA2065603C
(en)
|
1991-04-09 |
2007-04-03 |
Hiroki Itoh |
Stabilized vitamin d preparation
|
US5693615A
(en)
*
|
1991-06-05 |
1997-12-02 |
The Procter & Gamble Company |
Therapeutic compositions for osteoinduction
|
US6313146B1
(en)
|
1991-08-23 |
2001-11-06 |
Nps Pharmaceuticals, Inc. |
Calcium receptor-active molecules
|
US6011068A
(en)
|
1991-08-23 |
2000-01-04 |
Nps Pharmaceuticals, Inc. |
Calcium receptor-active molecules
|
US6031003A
(en)
|
1991-08-23 |
2000-02-29 |
Nps Pharmaceuticals, Inc. |
Calcium receptor-active molecules
|
US6001884A
(en)
|
1991-08-23 |
1999-12-14 |
Nps Pharmaceuticals, Inc. |
Calcium receptor-active molecules
|
US5266331A
(en)
|
1991-11-27 |
1993-11-30 |
Euroceltique, S.A. |
Controlled release oxycodone compositions
|
US5472712A
(en)
|
1991-12-24 |
1995-12-05 |
Euroceltique, S.A. |
Controlled-release formulations coated with aqueous dispersions of ethylcellulose
|
US5160742A
(en)
*
|
1991-12-31 |
1992-11-03 |
Abbott Laboratories |
System for delivering an active substance for sustained release
|
US5795882A
(en)
*
|
1992-06-22 |
1998-08-18 |
Bone Care International, Inc. |
Method of treating prostatic diseases using delayed and/or sustained release vitamin D formulations
|
JP3722832B2
(ja)
|
1992-06-22 |
2005-11-30 |
ルーナー、コーポレーション |
経口用1α−ヒドロキシプレビタミンD
|
US5354743A
(en)
*
|
1992-09-15 |
1994-10-11 |
Thys Jacobs Susan |
Method for the treatment of premenstrual syndrome with vitamin D
|
US5431917A
(en)
|
1992-10-08 |
1995-07-11 |
Japan Elanco Company, Ltd. |
Hard capsule for pharmaceutical drugs and method for producing the same
|
US5342626A
(en)
|
1993-04-27 |
1994-08-30 |
Merck & Co., Inc. |
Composition and process for gelatin-free soft capsules
|
JP2684587B2
(ja)
|
1993-06-21 |
1997-12-03 |
呉羽化学工業株式会社 |
腎性骨異栄養症における骨量減少抑制剤
|
US6121469A
(en)
|
1993-12-23 |
2000-09-19 |
The Regents Of The University Of California |
Therapeutically effective 1α,25-dihydroxyvitamin D3 analogs
|
JPH07242550A
(ja)
|
1994-03-02 |
1995-09-19 |
Teijin Ltd |
二次性副甲状腺機能亢進症治療剤
|
IL110117A0
(en)
|
1994-06-24 |
1994-10-07 |
Univ Ben Gurion |
Pharmaceutical compositions comprising vitamin-d analogs
|
SE9402422D0
(sv)
|
1994-07-08 |
1994-07-08 |
Astra Ab |
New beads for controlled release and a pharmaceutical preparation containing the same
|
WO1996003113A1
(en)
|
1994-07-22 |
1996-02-08 |
G.D. Searle & Co. |
Self-emulsifying drug delivery system
|
JPH0892098A
(ja)
|
1994-09-27 |
1996-04-09 |
Teijin Ltd |
肺結核治療剤
|
EP1275635A1
(en)
|
1994-10-21 |
2003-01-15 |
Nps Pharmaceuticals, Inc. |
Calcium receptor-active compounds
|
US5756123A
(en)
|
1994-12-01 |
1998-05-26 |
Japan Elanco Co., Ltd. |
Capsule shell
|
US6242434B1
(en)
|
1997-08-08 |
2001-06-05 |
Bone Care International, Inc. |
24-hydroxyvitamin D, analogs and uses thereof
|
US20040043971A1
(en)
*
|
1995-04-03 |
2004-03-04 |
Bone Care International, Inc. |
Method of treating and preventing hyperparathyroidism with active vitamin D analogs
|
US6376479B1
(en)
*
|
1995-04-03 |
2002-04-23 |
Bone Care International, Inc. |
Method for treating and preventing hyperparathyroidism
|
US20020183288A1
(en)
|
1995-04-03 |
2002-12-05 |
Bone Care International, Inc. |
Method for treating and preventing hyperparathyroidism
|
NZ501318A
(en)
|
1995-09-21 |
2001-07-27 |
Wisconsin Alumni Res Found |
Medicaments containing 25 hydroxy vitamin D (calcitriol) derivatives
|
DE19549243A1
(de)
|
1995-12-21 |
1997-06-26 |
Schering Ag |
Pharmazeutische Präparate enthaltend Clathrate von Cyclodextrinen und nichtnatürliche Vitamin D-Analoga
|
NO971934L
(no)
|
1996-05-23 |
1997-11-24 |
Hoffmann La Roche |
Flourinerte vitamin D3 -analoger
|
US5939408A
(en)
|
1996-05-23 |
1999-08-17 |
Hoffman-La Roche Inc. |
Vitamin D3 analogs
|
EP0949927B1
(en)
*
|
1996-08-26 |
2002-10-16 |
Takeda Chemical Industries, Ltd. |
Pharmaceutical composition containing osteogenesis-promoting substance and a polyethylene glycol
|
US5958451A
(en)
|
1996-09-03 |
1999-09-28 |
Yung Shin Pharm Ind. Co., Ltd. |
Process for producing porous, controlled-release capsules and encapsulated composition
|
US5976784A
(en)
|
1996-09-20 |
1999-11-02 |
Wisconsin Alumni Research Foundation |
Calcitriol derivatives and their uses
|
US8828432B2
(en)
*
|
1996-10-28 |
2014-09-09 |
General Mills, Inc. |
Embedding and encapsulation of sensitive components into a matrix to obtain discrete controlled release particles
|
WO1998018610A1
(en)
|
1996-10-28 |
1998-05-07 |
Lengerich Bernhard H Van |
Embedding and encapsulation of controlled release particles
|
JPH10158171A
(ja)
|
1996-12-02 |
1998-06-16 |
Kita:Kk |
ビタミンd化合物を配合した眼内投与剤
|
US6503893B2
(en)
|
1996-12-30 |
2003-01-07 |
Bone Care International, Inc. |
Method of treating hyperproliferative diseases using active vitamin D analogues
|
US20020128240A1
(en)
|
1996-12-30 |
2002-09-12 |
Bone Care International, Inc. |
Treatment of hyperproliferative diseases using active vitamin D analogues
|
US20030129194A1
(en)
|
1997-02-13 |
2003-07-10 |
Bone Care International, Inc. |
Targeted therapeutic delivery of vitamin D compounds
|
US6034075A
(en)
|
1997-03-20 |
2000-03-07 |
The Trustees Of Columbia University In The City Of New York |
Method of treating polycystic ovarian syndrome
|
US5872113A
(en)
|
1997-05-16 |
1999-02-16 |
Syntex (U.S.A.) Inc. |
Fluorinated vitamin D3 analogs
|
DE69834195T2
(de)
|
1997-07-02 |
2007-03-29 |
Euro-Celtique S.A. |
Stabilisierte tramadol formulierungen mit verzögerter freisetzung
|
JPH1175863A
(ja)
|
1997-07-10 |
1999-03-23 |
Kyowa Hakko Kogyo Co Ltd |
25−ヒドロキシビタミンD3−1α−水酸化酵素および該酵素をコードするDNA
|
US6096876A
(en)
|
1997-08-06 |
2000-08-01 |
Shriners Hospitals For Children |
1-α-hydroxylase materials and methods
|
AU9376998A
(en)
|
1997-09-02 |
1999-03-22 |
Johns Hopkins University School Of Medicine, The |
Vitamin d3 analog loaded polymer formulations for cancer and neurodegenerative disorders
|
US5919986A
(en)
|
1997-10-17 |
1999-07-06 |
Hoffmann-La Roche Inc. |
D-homo vitamin D3 derivatives
|
JPH11158074A
(ja)
|
1997-12-03 |
1999-06-15 |
Hayashi Tomie |
高アミノ酸付加活性型ビタミンd強化組成物
|
US20030059471A1
(en)
*
|
1997-12-15 |
2003-03-27 |
Compton Bruce Jon |
Oral delivery formulation
|
JP2002507415A
(ja)
|
1998-03-25 |
2002-03-12 |
キュタノジェン, インコーポレイテッド |
癌の予防および処置のための方法
|
AU762481C
(en)
|
1998-03-27 |
2004-08-19 |
Oregon Health Sciences University |
Vitamin D and its analogs in the treatment of tumors and other hyperproliferative disorders
|
US6197340B1
(en)
|
1998-05-28 |
2001-03-06 |
Medical Research Institute |
Controlled release lipoic acid
|
US8133694B2
(en)
|
1998-06-25 |
2012-03-13 |
Immundiagnostik Ag |
Functional vitamin D derivatives and method of determining 25-hydroxy- and 1α, 25-dihydroxy vitamin D
|
US6214376B1
(en)
|
1998-08-25 |
2001-04-10 |
Banner Pharmacaps, Inc. |
Non-gelatin substitutes for oral delivery capsules, their composition and process of manufacture
|
PT1039882E
(pt)
|
1998-08-27 |
2011-01-03 |
Pfizer Health Ab |
Formulação terapêutica para administrar tolterodina com libertação controlada
|
SE9803871D0
(sv)
|
1998-11-11 |
1998-11-11 |
Pharmacia & Upjohn Ab |
Therapeutic method and formulation
|
US6139875A
(en)
*
|
1998-09-29 |
2000-10-31 |
Eastman Chemical Company |
Aqueous enteric coating composition and low gastric permeability enteric coating
|
WO2000018374A1
(en)
|
1998-10-01 |
2000-04-06 |
Elan Pharma International, Ltd. |
Controlled release nanoparticulate compositions
|
DE69940821D1
(de)
|
1998-10-09 |
2009-06-10 |
Gen Mills Inc |
Verkapselung empfindlicher flüssiger komponenten in eine matrix zur gewinnung diskreter lagerbeständiger partikel
|
JP3449253B2
(ja)
|
1998-10-29 |
2003-09-22 |
シオノギクオリカプス株式会社 |
硬質カプセルの製造方法
|
JP2000206312A
(ja)
|
1998-11-12 |
2000-07-28 |
Olympus Optical Co Ltd |
光学素子
|
DE69915346T2
(de)
|
1998-12-17 |
2004-07-22 |
Alza Corp., Mountain View |
Umwandlung von flüssigkeitsgefüllten gelatinkapseln in systeme mit gesteuerter wirkstoffabgabe durch mehrfache beschichtungen
|
US6342249B1
(en)
*
|
1998-12-23 |
2002-01-29 |
Alza Corporation |
Controlled release liquid active agent formulation dosage forms
|
US6432936B1
(en)
*
|
1999-01-20 |
2002-08-13 |
Wisconsin Alumni Research Foundation |
Crystalline 1α-hydroxyvitamin D2 and method of purification thereof
|
US6248363B1
(en)
|
1999-11-23 |
2001-06-19 |
Lipocine, Inc. |
Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
|
US6380408B1
(en)
*
|
1999-04-01 |
2002-04-30 |
The Johns Hopkins University |
Non-calcemic, antiproliferative, transcriptionally active sulfur-containing analogs of 1α, 25-dihydroxy vitamin D3
|
US7648826B1
(en)
|
1999-04-02 |
2010-01-19 |
The Regents Of The University Of California |
Detecting CYP24 expression level as a marker for predisposition to cancer
|
DE19916419B4
(de)
|
1999-04-08 |
2005-06-16 |
Schering Ag |
Kombinationspräparat aus Vitamin-D-Metaboliten oder Vitamin-D-Analoga und einem Östrogenpartialagonisten zur Behandlung von Osteoporose
|
AU5139600A
(en)
*
|
1999-05-27 |
2000-12-18 |
Drugtech Corporation |
Nutritional formulations
|
US6340473B1
(en)
|
1999-07-07 |
2002-01-22 |
R.P. Scherer Technologies, Inc. |
Film forming compositions comprising modified starches and iota-carrageenan and methods for manufacturing soft capsules using same
|
US6051567A
(en)
*
|
1999-08-02 |
2000-04-18 |
Abbott Laboratories |
Low oxygen content compositions of 1α, 25-dihydroxycholecalciferol
|
US6274169B1
(en)
*
|
1999-08-02 |
2001-08-14 |
Abbott Laboratories |
Low oxygen content compostions of 1α, 25-dihydroxycholecalciferol
|
WO2001015702A1
(fr)
|
1999-08-31 |
2001-03-08 |
Chugai Seiyaku Kabushiki Kaisha |
Capsules molles
|
US20060034937A1
(en)
|
1999-11-23 |
2006-02-16 |
Mahesh Patel |
Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
|
GB0007419D0
(en)
|
2000-03-27 |
2000-05-17 |
Smithkline Beecham Gmbh |
Composition
|
US6375981B1
(en)
|
2000-06-01 |
2002-04-23 |
A. E. Staley Manufacturing Co. |
Modified starch as a replacement for gelatin in soft gel films and capsules
|
IL153378A0
(en)
|
2000-07-18 |
2003-07-06 |
Bone Care Internat Inc |
STABILIZED 1alpha-HYDROXY VITAMIN D
|
US6491950B1
(en)
|
2000-08-07 |
2002-12-10 |
Kos Pharmaceuticals, Inc. |
Controlled release pharmaceutical composition
|
WO2002012182A1
(fr)
*
|
2000-08-08 |
2002-02-14 |
Chugai Seiyaku Kabushiki Kaisha |
Derives de 3-methyl-20-epi-vitamine d
|
EP1323404B1
(en)
|
2000-08-29 |
2013-10-16 |
Nisshin Kasei Co.,Ltd. |
Hard capsule
|
US6887493B2
(en)
|
2000-10-25 |
2005-05-03 |
Adi Shefer |
Multi component controlled release system for oral care, food products, nutraceutical, and beverages
|
EP1337244A4
(en)
|
2000-10-30 |
2006-01-11 |
Euro Celtique Sa |
HYDROCODON FORMULATIONS WITH CONTROLLED RELEASE
|
US6479649B1
(en)
|
2000-12-13 |
2002-11-12 |
Fmc Corporation |
Production of carrageenan and carrageenan products
|
JP2002302447A
(ja)
*
|
2001-04-03 |
2002-10-18 |
Shimizu Pharmaceutical Co Ltd |
局所投与用癌治療剤
|
RU2262922C2
(ru)
|
2001-05-15 |
2005-10-27 |
Уорнер-Ламберт Компани Ллс |
Способ прессования для получения лекарственной формы фенитоина натрия
|
CN100366239C
(zh)
|
2001-07-05 |
2008-02-06 |
涌永制药株式会社 |
软胶囊剂
|
US6870833B2
(en)
|
2001-07-20 |
2005-03-22 |
Net2Phone, Inc. |
Active voice messaging
|
US7166585B2
(en)
|
2001-08-22 |
2007-01-23 |
Cytochroma Inc. |
24-Sulfur-substituted analogs of 1α,25-dihydroxy vitamin D3
|
US7033996B2
(en)
|
2001-08-31 |
2006-04-25 |
University Of Medicine & Dentistry Of New Jersey |
Method for the treatment of vitamin D related disease
|
DE10149674A1
(de)
|
2001-10-09 |
2003-04-24 |
Apogepha Arzneimittel Gmbh |
Orale Darreichungsformen für Propiverin oder seinen pharmazeutisch annehmbaren Salzen mit verlängerter Wirkstoffreisetzung
|
DK1436257T3
(da)
*
|
2001-10-12 |
2007-06-25 |
Univ Johns Hopkins |
Oxim-analogica af 1-alpha, 25-dihydroxy-vitamin-D3 med ringe kalcemisk virkning
|
US6524788B1
(en)
|
2001-11-02 |
2003-02-25 |
Thomas L. Cantor |
Methods for monitoring and guiding therapeutic suppression of parathyroid hormone in renal patients having secondary hyperparathyroidism
|
US7056655B2
(en)
|
2001-11-02 |
2006-06-06 |
Scantibodies Laboratory, Inc. |
Methods for monitoring and guiding therapeutic suppression of parathyroid hormone in renal patients having secondary hyperparathyroidism
|
ITMI20012366A1
(it)
|
2001-11-09 |
2003-05-09 |
Farmatron Ltd |
Sistemi terapeutici stabilizzati a rilascio immediato e/o modificato per la somministrazione orale di principi attivi e/o eccipienti e/o ali
|
US7255921B2
(en)
|
2001-11-22 |
2007-08-14 |
Morishita Jintan Co., Ltd. |
Non-gelatinous capsule shell composition and a capsule formed from the same
|
GB0128415D0
(en)
|
2001-11-27 |
2002-01-16 |
Univ Sheffield |
Medicaments
|
WO2003047595A1
(en)
|
2001-12-03 |
2003-06-12 |
Novacea, Inc. |
Pharmaceutical compositions comprising active vitamin d compounds
|
US6627622B2
(en)
|
2002-02-18 |
2003-09-30 |
Wisconsin Alumni Research Foundation |
(20S)-1α-hydroxy-2-methylene-19-nor-bishomopregnacalciferol and its uses
|
FR2829142B1
(fr)
|
2001-12-27 |
2004-02-13 |
Ulice |
Composition filmogene d'heteroxylanes pour la fabrication de capsules ainsi obtenues
|
US7632518B2
(en)
|
2002-01-15 |
2009-12-15 |
Dsm Ip Assets B.V. |
25-hydroxy vitamin D3 compositions
|
US6949256B2
(en)
|
2002-01-18 |
2005-09-27 |
Banner Pharmacaps, Inc. |
Non-gelatin capsule shell formulation
|
NO20021592D0
(no)
|
2002-04-04 |
2002-04-04 |
Fmc Biopolymer As |
Polysakkaridkapsler og fremgangsmåte ved fremstilling derav
|
AU2003226148A1
(en)
|
2002-04-05 |
2003-10-27 |
Merck & Co., Inc. |
Method for inhibiting bone resorption with an alendronate and vitamin d formulation
|
NZ536267A
(en)
|
2002-04-10 |
2007-06-29 |
Fred H Miller |
Multi-phase, multi-compartment and multi-ingredient capsular system
|
US7288407B2
(en)
|
2002-05-02 |
2007-10-30 |
Cytochroma, Inc. |
Stable cytochrome P450 24 (CYP24) expressing cell line and methods and uses thereof
|
AU2003233735A1
(en)
|
2002-06-13 |
2003-12-31 |
Cytochroma Inc. |
24-sulfoximine vitamin d3 compounds
|
WO2004004696A1
(en)
|
2002-07-05 |
2004-01-15 |
Temrel Inc. |
Controlled release composition
|
US7655717B2
(en)
*
|
2002-07-17 |
2010-02-02 |
Mary J. Goulbourne |
Ointment composition for treating decubitus ulcers and methods for its making and its use
|
MY142179A
(en)
|
2002-07-25 |
2010-10-15 |
Glaxo Group Ltd |
Multicomponent pharmaceutical dosage form
|
US20040092534A1
(en)
|
2002-07-29 |
2004-05-13 |
Yam Nyomi V. |
Methods and dosage forms for controlled delivery of paliperidone
|
US8268352B2
(en)
|
2002-08-05 |
2012-09-18 |
Torrent Pharmaceuticals Limited |
Modified release composition for highly soluble drugs
|
AU2002368245A1
(en)
|
2002-09-26 |
2004-04-19 |
Young-Kweon Choi |
Matrix type patch for transdermal administration of vitamin d analog and the use thereof
|
US20050101576A1
(en)
|
2003-11-06 |
2005-05-12 |
Novacea, Inc. |
Methods of using vitamin D compounds in the treatment of myelodysplastic syndromes
|
US8999372B2
(en)
|
2002-11-14 |
2015-04-07 |
Cure Pharmaceutical Corporation |
Methods for modulating dissolution, bioavailability, bioequivalence and drug delivery profile of thin film drug delivery systems, controlled-release thin film dosage formats, and methods for their manufacture and use
|
JP2004175750A
(ja)
|
2002-11-28 |
2004-06-24 |
Kose Corp |
皮膚障害抑制剤、皮膚障害改善剤、及びそれらを含有する皮膚外用剤
|
US20050026877A1
(en)
|
2002-12-03 |
2005-02-03 |
Novacea, Inc. |
Pharmaceutical compositions comprising active vitamin D compounds
|
DE20321698U1
(de)
|
2002-12-16 |
2008-12-24 |
Teva Pharmaceutical Industries Ltd. |
Medikament zur Erhöhung der Bioverfügbarkeit von Alendronat oder einem anderen Bisphosphonat durch Verabreichen einer Vordosis eines Vitamin-D-Derivats
|
WO2004058235A2
(en)
*
|
2002-12-16 |
2004-07-15 |
Teva Pharmaceutical Industries Ltd. |
Method of increasing bioavailability of alendronate or other bis-phosphonate by predose administration of vitamin d derivative
|
CA2510228C
(en)
|
2002-12-18 |
2012-10-30 |
Johns Hopkins University |
25-so2-substituted analogs of 1.alpha.,25-dihydroxyvitamin d3
|
ATE401866T1
(de)
|
2003-02-11 |
2008-08-15 |
Alza Corp |
Verfahren und dosierformen mit modifizierter schichtgeometrie
|
BRPI0409329A
(pt)
|
2003-04-14 |
2006-04-25 |
Fmc Corp |
processo para fabricar pelìculas de gel termorreversìveis, homogêneas, pelìcula homogênea, termorreversìvel, de sólidos altos, umidade baixa, processo para fabricar cápsulas moles, cápsulas moles, processo para fabricar uma forma de dosagem sólida, forma sólida, processo para preparar uma sistema de liberação de pelìcula de gel homogênea, e, sistema de liberação
|
US7816341B2
(en)
|
2003-04-14 |
2010-10-19 |
Fmc Corporation |
Homogeneous, thermoreversible gel containing reduced viscosity carrageenan and products made therefrom
|
WO2004098507A2
(en)
|
2003-04-30 |
2004-11-18 |
Bioxell S.P.A. |
1,3 aclyated 24-keto-vitamin d3 compounds and methods of use thereof
|
US20060216358A1
(en)
|
2003-05-07 |
2006-09-28 |
Christian Hansen |
Controlled release composition containing a strontium salt
|
EP1479677A1
(en)
|
2003-05-19 |
2004-11-24 |
Aventis Pharma Deutschland GmbH |
New indole derivatives as factor xa inhibitors
|
EP1638508B1
(en)
|
2003-06-16 |
2014-08-13 |
Solx, Inc. |
Shunt for the treatment of glaucoma
|
TWI367103B
(en)
*
|
2003-06-26 |
2012-07-01 |
Psivida Inc |
Bioerodible sustained release drug delivery systems
|
AU2003903382A0
(en)
|
2003-07-03 |
2003-07-17 |
Medvet Science Pty Ltd |
Inhibition of calcitriol mediated cyp24 induction screening for compounds therefor and uses thereof
|
CN1816324A
(zh)
|
2003-07-04 |
2006-08-09 |
尼克麦德丹麦公司 |
口服用的含甲状旁腺激素(pth)的药物组合物
|
US20050148557A1
(en)
*
|
2003-07-29 |
2005-07-07 |
Jin Tian |
Use of Vitamin Ds to treat kidney disease
|
US20050124591A1
(en)
*
|
2003-07-29 |
2005-06-09 |
Jin Tian |
Use of vitamin Ds to treat kidney disease
|
ES2655435T3
(es)
|
2003-09-12 |
2018-02-20 |
Amgen Inc. |
Formulación de disolución rápida de cinacalcet
|
WO2005051396A2
(en)
|
2003-11-25 |
2005-06-09 |
Deltanoid Pharmaceuticals, Inc. |
Methods for reducing body fat using vitamin d compounds
|
US7427670B2
(en)
|
2003-12-19 |
2008-09-23 |
Cytochroma Inc. |
Cytochrome P450 24 (CYP24) monoclonal antibody and methods and uses thereof
|
US20060009425A1
(en)
|
2004-05-28 |
2006-01-12 |
Leticia Delgado-Herrera |
Oral formulations of paricalcitol
|
JP2008502605A
(ja)
|
2004-06-16 |
2008-01-31 |
スマート ドラッグ システムズ インコーポレイティド |
徐放性ワクチン組成物
|
WO2006007323A2
(en)
|
2004-06-28 |
2006-01-19 |
Alza Corporation |
Dosage forms for low solubility and/or low dissolution rate free acid pharmaceutical agents
|
US20060019933A1
(en)
|
2004-07-22 |
2006-01-26 |
David Boardman |
Process for preparing stabilized vitamin D
|
KR20070043806A
(ko)
|
2004-07-29 |
2007-04-25 |
사노피-아벤티스 |
pH에 매우 의존적인 용해도를 가지는 활성 성분의 제어방출을 위한 약제학적 다층 정제
|
US8231896B2
(en)
|
2004-11-08 |
2012-07-31 |
R.P. Scherer Technologies, Llc |
Non-gelatin soft capsule system
|
AU2004325362B2
(en)
|
2004-12-03 |
2012-09-06 |
Council Of Scientific And Industrial Research |
Process of preparation of biodegradable films from semi refined kappa carrageenan
|
US8318210B2
(en)
*
|
2005-02-28 |
2012-11-27 |
Neos Therapeutics, Lp |
Compositions and methods of making sustained release liquid formulations
|
US7745226B2
(en)
|
2005-04-06 |
2010-06-29 |
Quest Diagnostics Investments Incorporated |
Methods for detecting vitamin D metabolites
|
EP2985026B1
(en)
|
2005-04-15 |
2022-08-03 |
Clarus Therapeutics, Inc. |
Pharmaceutical delivery systems for hydrophobic drugs and compositions comprising same
|
US20060257481A1
(en)
|
2005-04-21 |
2006-11-16 |
Decode Genetics Ehf. |
Sustained release formulation and dosing schedule of leukotriene synthesis inhibitor for human therapy
|
US9205047B2
(en)
|
2005-04-25 |
2015-12-08 |
The Governing Council Of The University Of Toronto |
Tunable sustained release of a sparingly soluble hydrophobic therapeutic agent from a hydrogel matrix
|
US20080134937A1
(en)
|
2005-05-25 |
2008-06-12 |
Joo Hwan Yang |
Cellulose hard capsule enhancing mechanical film strength
|
AR055099A1
(es)
|
2005-07-28 |
2007-08-08 |
Alza Corp |
Formulaciones liquidas para la administracion controlada de derivados de bencisoxazol
|
ATE427965T1
(de)
|
2005-09-29 |
2009-04-15 |
Hoffmann La Roche |
Antikírper gegen 25-hydroxyvitamin d
|
ITFI20050206A1
(it)
|
2005-09-30 |
2007-04-01 |
Valpharma Sa |
Composizione farmaceutica a rilascio controllato di venlafaxina cloridrato, e processo per la sua preparazione
|
US20070122477A1
(en)
|
2005-10-12 |
2007-05-31 |
Cytochroma, Inc. |
Methods and articles for treating 25-hydroxyvitamin D insufficiency and deficiency
|
CN101360485B
(zh)
|
2005-10-26 |
2013-04-17 |
班纳制药公司 |
作为胶囊填充物的基于亲水性载体的双重控释基质***
|
US8293270B2
(en)
|
2005-10-26 |
2012-10-23 |
Banner Pharmacaps, Inc. |
Lipophilic vehicle-based dual controlled release matrix system
|
KR20080106160A
(ko)
|
2005-11-01 |
2008-12-04 |
씨피 켈코 유에스, 인코포레이티드 |
변성 카르복시메틸셀룰로오스 물질로 제조된 필름 및 캡슐및 그의 제조방법
|
WO2007068287A1
(en)
|
2005-12-15 |
2007-06-21 |
Laboratoria Qualiphar |
Sustained release vitamin preparation
|
MXPA05014091A
(es)
|
2005-12-20 |
2007-06-20 |
Leopoldo De Jesus Espinosa Abdala |
Composiciones farmaceuticas que comprenden derivados de esteroides sinteticos, minerales y el metabolito activo de la vitamina d, 1,25(oh)2d3 (calcitriol) para la prevencion y tratamiento de la osteoporosis y el control de los sintomas de la menopaus
|
CN101448955A
(zh)
|
2006-01-31 |
2009-06-03 |
健康研究股份有限公司 |
鉴定维生素d代谢改变的方法
|
US7528122B2
(en)
|
2006-02-02 |
2009-05-05 |
Wisconsin Alumni Research Foundation |
Vitamin D analog—NEL, methods and uses thereof
|
EP3095447B1
(en)
|
2006-02-03 |
2021-11-24 |
OPKO Renal, LLC |
Treating vitamin d insufficiency and deficiency with 25-hydroxyvitamin d2 and 25-hydroxyvitamin d3
|
GB0606426D0
(en)
|
2006-03-30 |
2006-05-10 |
Novartis Ag |
Benzimidazole derivatives
|
EP2024436A1
(en)
|
2006-06-06 |
2009-02-18 |
Fmc Corporation |
Kappa-2 carrageenan composition and products made therefrom
|
US20080109983A1
(en)
|
2006-11-10 |
2008-05-15 |
Kegel, Llc |
Zero Turning Radius Lane Maintenance Machine
|
PT2037936E
(pt)
|
2006-06-21 |
2014-09-04 |
Opko Renal Llc |
Método de tratamento e prevenção do hiperparatiroidismo secundário
|
EP1912400A1
(en)
|
2006-10-10 |
2008-04-16 |
Matsushita Electric Industrial Co., Ltd. |
Method and apparatus for mobile IP route optimization
|
KR101170283B1
(ko)
|
2006-10-27 |
2012-07-31 |
화이자 프로덕츠 인코포레이티드 |
하이드록시프로필 메틸 셀룰로스 경질 캡슐 및 이의 제조 방법
|
WO2008097646A1
(en)
|
2007-02-09 |
2008-08-14 |
Schering Corporation |
Methods to treat and/or prevent mucositis
|
US8491937B2
(en)
|
2007-02-15 |
2013-07-23 |
Wyeth Llc |
Stability in vitamin and mineral supplements
|
WO2008116113A1
(en)
|
2007-03-20 |
2008-09-25 |
Electrolock, Inc. |
Roebel winding with conductive felt
|
EP2136814A4
(en)
|
2007-03-21 |
2012-05-30 |
Univ Duke |
MEDICAL KITS AND FORMULATIONS FOR PREVENTING, TREATING OR REDUCING SECONDARY FRACTURES FROM A PREVIOUS FRACTURE
|
WO2008134518A2
(en)
|
2007-04-25 |
2008-11-06 |
Cytochroma Inc. |
Methods and compounds for vitamin d therapy
|
US20100144684A1
(en)
|
2007-04-25 |
2010-06-10 |
Proventiv Therapeutics, Inc. |
Method of Safely and Effectively Treating and Preventing Secondary Hyperparathyroidism in Chronic Kidney Disease
|
CN104523707B
(zh)
|
2007-04-25 |
2022-08-26 |
欧普科Ip 控股Ii 有限公司 |
包含维生素d化合物和蜡质载体的口服控释组合物
|
US11752158B2
(en)
|
2007-04-25 |
2023-09-12 |
Eirgen Pharma Ltd. |
Method of treating vitamin D insufficiency and deficiency
|
US20090004284A1
(en)
|
2007-06-26 |
2009-01-01 |
Watson Pharmaceuticals, Inc. |
Controlled release tamsulosin hydrochloride formulation
|
KR100836960B1
(ko)
|
2007-09-07 |
2008-06-10 |
주식회사 서울제약 |
새로운 나이아신 제어방출형 제제
|
EP2042165A1
(de)
|
2007-09-28 |
2009-04-01 |
Swiss Caps Rechte und Lizenzen AG |
Hot-Melt-Befüllte Weichkapseln
|
AU2007362356A1
(en)
|
2007-12-12 |
2009-06-18 |
Northern Innovations And Formulations Corp. |
Particles in a capsule
|
WO2009101136A1
(en)
|
2008-02-13 |
2009-08-20 |
Dsm Ip Assets B.V. |
Treating hyperglycemia with 25-hydroxyvitamin d3
|
EP2249842B1
(en)
|
2008-02-13 |
2016-07-27 |
DSM IP Assets B.V. |
Use of 25-hydroxy-vitamin d3 and vitamin d to affect human muscle physiology
|
US20110118218A1
(en)
|
2008-02-13 |
2011-05-19 |
Neil Robert Buck |
Treating hypertension with 25-hydroxyvitamin d3
|
MX2010008894A
(es)
|
2008-02-13 |
2010-11-05 |
Dsm Ip Assets Bv |
Combinacion de vitamina d y 25-hidroxi-vitamina d3.
|
WO2009101135A1
(en)
|
2008-02-13 |
2009-08-20 |
Dsm Ip Assets B.V. |
Combined use of 25-hydroxy-vitamin d3 and vitamin d3 for improving bone mineral density and for treating osteoporosis
|
KR101685031B1
(ko)
|
2008-04-02 |
2016-12-09 |
사이토크로마 인코포레이티드 |
비타민 d 결핍 및 관련 장애에 유용한 방법, 조성물, 용도 및 키트
|
SI2321273T1
(sl)
|
2008-07-24 |
2015-03-31 |
Wisconsin Alumni Research Foundation |
Enkrat tedensko dajanje 25-hidroksi-vitamina D3 za vzdrževanje povišane stacionarne farmakokinetične krvne koncentracije
|
SI2341899T1
(sl)
|
2008-09-24 |
2015-04-30 |
Evonik Roehm Gmbh |
Od pH odvisen opioidni farmacevtski sestavek z nadzorovanim sproščanjem z odpornostjo na vpliv etanola
|
ES2425762T3
(es)
|
2008-10-27 |
2013-10-17 |
Roquette Freres |
Polímero insoluble en agua: revestimientos de película a base de derivados de almidón modificado para la liberación dirigida al colon
|
EA026651B1
(ru)
|
2009-01-23 |
2017-05-31 |
Ацьенде Кимике Рьюните Анджелини Франческо А.К.Р.А.Ф. С.П.А. |
Фармацевтический или пищевой состав с контролируемым высвобождением и способ его получения
|
CH700543A2
(de)
|
2009-03-03 |
2010-09-15 |
Innogel Ag |
Film auf Basis von Stärke.
|
EP2475394B1
(en)
|
2009-09-10 |
2019-03-20 |
DuPont Nutrition USA, Inc. |
Seamless alginate capsules
|
IT1396937B1
(it)
|
2009-11-26 |
2012-12-20 |
Bruzzese |
Formulazioni di bisfosfonati e vitamina d idonee alla somministrazione intermittente per via intramuscolare e sottocutanea
|
FR2953139B1
(fr)
|
2009-11-27 |
2012-04-13 |
Servier Lab |
Composition pharmaceutique comprenant un sel de strontium, de la vitamine d et une cyclodextrine
|
US8101203B2
(en)
|
2010-01-14 |
2012-01-24 |
Karl Wei Cao |
Hard capsule composition and method of use
|
US8101204B2
(en)
|
2010-01-14 |
2012-01-24 |
Karl Wei Cao |
Hard capsule composition and method of use
|
WO2011095388A1
(en)
|
2010-02-04 |
2011-08-11 |
Synthon Bv |
Tolterodine bead
|
WO2011123476A1
(en)
|
2010-03-29 |
2011-10-06 |
Cytochroma Inc. |
Methods and compositions for reducing parathyroid levels
|
EP2591354B1
(en)
|
2010-07-07 |
2016-09-07 |
Ardelyx, Inc. |
Compounds and methods for inhibiting phosphate transport
|
KR20120005228A
(ko)
|
2010-07-08 |
2012-01-16 |
주식회사 네비팜 |
골다공증 치료용 비스포스폰산 함유 장용 약학조성물 및 그의 제조방법
|
BR112013002721B8
(pt)
|
2010-08-04 |
2021-05-25 |
Scherer Technologies Llc R P |
composição formadora de filme para cápsulas moles, cápsulas moles e seu invólucro
|
US20120135103A1
(en)
|
2010-11-30 |
2012-05-31 |
Mead Johnson Nutrition Company |
Staged Infant Feeding Regimen To Promote Healthy Development And Growth
|
KR101895764B1
(ko)
|
2010-12-06 |
2018-09-07 |
디에스엠 아이피 어셋츠 비.브이. |
25-하이드록시비타민 d3을 사용한, 증가된 에오탁신과 관련된 질환의 치료
|
EP2635611B1
(en)
|
2010-12-28 |
2017-01-11 |
Future Diagnostics B.V. |
Release reagent for vitamin d
|
GB2502032B
(en)
|
2011-03-02 |
2015-03-04 |
D3 Pharma Ltd |
Stable Vitamin D3 Composition
|
EP2700415B1
(en)
|
2011-04-20 |
2016-11-30 |
Suheung Co., Ltd. |
Non-animal soft capsule shell composition having improved disintegration and shell hardness
|
SG194542A1
(en)
|
2011-04-20 |
2013-12-30 |
Mico Bio Inc |
Composition and method for enhancing an immune response
|
CN102771688A
(zh)
|
2011-05-13 |
2012-11-14 |
富曼实(上海)商贸有限公司 |
可食用液体填充的多糖胶囊
|
US20130085121A1
(en)
|
2011-09-30 |
2013-04-04 |
Jianguo Wang |
Pharmaceutical compositions comprising phosphate binder, calcium receptor-active compound and/or active vitamin d
|
WO2014029953A1
(en)
|
2012-08-21 |
2014-02-27 |
Cipla Limited |
Hot melt extruded (hme) pharmaceutical composition of cinacalcet
|
KR101847947B1
(ko)
|
2013-03-15 |
2018-05-28 |
옵코 아이피 홀딩스 Ⅱ 인코포레이티드 |
안정화되고 변형된 비타민 d 방출 제형
|
PT106978A
(pt)
|
2013-05-31 |
2014-12-02 |
Tecnimede Sociedade Tecnico Medicinal S A |
Composição sólida oral contendo ácido ibandrónico e vitamina d
|
EP2815745A1
(en)
|
2013-06-21 |
2014-12-24 |
Swiss Caps Rechte und Lizenzen AG |
Soft shell capsule and process for its manufacture
|
CN103520133B
(zh)
|
2013-10-26 |
2015-02-04 |
中山市凯博思淀粉材料科技有限公司 |
一种淀粉基软胶囊的制备方法
|
CN103495176B
(zh)
|
2013-10-26 |
2015-01-28 |
中山市凯博思淀粉材料科技有限公司 |
一种共混挤出法制备淀粉基软胶囊的方法
|
CR20170085A
(es)
|
2014-08-07 |
2017-04-25 |
Opko Ireland Global Holdings Ltd |
Terapia adjuntiva con 25-hidroxi vitamina d
|